Amrize Ltd (NYSE:AMRZ – Get Free Report) has received a consensus rating of “Moderate Buy” from the seventeen analysts that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $64.1429.
AMRZ has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price target on Amrize from $59.00 to $66.00 and gave the stock an “overweight” rating in a research note on Thursday, February 19th. Weiss Ratings downgraded shares of Amrize from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. Stephens initiated coverage on shares of Amrize in a research report on Friday, November 14th. They issued an “overweight” rating and a $60.00 price target for the company. Oppenheimer reaffirmed an “outperform” rating and issued a $70.00 price objective (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Finally, UBS Group boosted their target price on shares of Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, January 8th.
Read Our Latest Research Report on AMRZ
Insiders Place Their Bets
Hedge Funds Weigh In On Amrize
Several institutional investors and hedge funds have recently bought and sold shares of the business. MCF Advisors LLC acquired a new position in shares of Amrize in the 4th quarter valued at about $27,000. State of Wyoming purchased a new position in Amrize during the third quarter valued at approximately $32,000. Basepoint Wealth LLC acquired a new position in Amrize in the 4th quarter valued at approximately $33,000. Laurel Wealth Advisors LLC acquired a new position in Amrize in the 4th quarter valued at approximately $34,000. Finally, US Bancorp DE purchased a new stake in Amrize in the 3rd quarter worth approximately $38,000.
Amrize Price Performance
Shares of NYSE:AMRZ opened at $61.60 on Friday. The company has a market capitalization of $34.07 billion and a PE ratio of 25.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The stock has a fifty day moving average of $57.58 and a 200-day moving average of $53.37. Amrize has a one year low of $44.12 and a one year high of $65.94.
Amrize (NYSE:AMRZ – Get Free Report) last announced its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The firm’s revenue was down .4% compared to the same quarter last year.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Stories
- Five stocks we like better than Amrize
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
